Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Erbliche Bronchial- und Lungenerkrankungen

Die große Gruppe hereditärer broncho-pulmonaler Erkrankungen umfasst die verschiedenensten Störungen des Zellstoffwechsels und der Membranfunktion, aber auch Fehlfunktionen im Muskel- und Skelettsystem wirken sich nachteilig auf die Lungenfunktion aus.

Gliederung

Genetisch bedingte Erkrankungen
Erbliche Augenerkrankungen und Sehstörungen
Erbliche Blutkrankheiten und Gerinnungsstörungen
Erbliche Bronchial- und Lungenerkrankungen
Bronchiektasien mit und ohne erhöhtem Chlorid im Schweiß
Bronchiektasien mit und ohne erhöhtem Chlorid im Schweiß 1
SCNN1B
Bronchiektasien mit und ohne erhöhtem Chlorid im Schweiß 2
SCNN1A
Bronchiektasien mit und ohne erhöhtem Chlorid im Schweiß 3
SCNN1G
Cystinose
CTNS
Hereditäre pulmonale Embolie
Venöse thromboembolische Erkrankungen
Autosomal dominanter Protein C-Mangel
PROC
Autosomal dominanter Protein S-Mangel
PROS1
Autosomal rezessiver Protein C-Mangel
PROC
Autosomal rezessiver Protein S-Mangel
PROS1
F2
F5
Faktor XII-Mangel
F12
HABP2
Hyperhomozysteinämie bedingte Thrombose
CBS
Hypoplasminogenemie
Dysplasminogenemie
PLG
Hypoplasminogenemie
PLG
MTHFR
PAI-Transkriptionsmodulator
SERPINE1
Protein Z-Mangel
PROZ
SERPINA10
SERPINC1
THBD
Thrombophilie durch Heparin-Kofaktor 2-Mangel
SERPIND1
VKORC1
Morbus Fabry
GLA
Neigung zu nächtlichem Asthma
ADRB2
Pulmonale alveoläre Mikrolithiasis
SLC34A2
Vermindertes Ansprechen auf beta-2-Mimetika
ADRB2
Erbliche Erkrankungen des Muskel- und Skelettsystems
Erbliche Erkrankungen im Hals-Nasen-Ohren-Bereich
Erbliche Fehlbildungen
Erbliche Gefäßerkrankungen
Erbliche Hauterkrankungen
Erbliche Herzerkrankungen
Erbliche Infektionsanfälligkeiten
Erbliche Lebererkrankungen
Erbliche Nervenerkrankungen
Erbliche Nierenerkrankungen
Erbliche Pankreaserkrankungen
Erbliche Stoffwechselerkrankungen
Erbliche Tumorerkrankungen
Erbliche endokrinologische Erkrankungen
Erbliche immunologische Erkrankungen
Erblicher Bluthochdruck
Genetische Einflüsse auf Arzneimittel-Verträglichkeit

Referenzen:

1.

De Rose V et al. (2005) Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.

external link
2.

Audrézet MP et al. (2002) Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.

external link
3.

Orita M et al. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

external link
4.

Fajac I et al. (2008) Could a defective epithelial sodium channel lead to bronchiectasis.

external link
5.

None (1991) Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada).

external link
6.

Savov A et al. (1995) Double mutant alleles: are they rare?

external link
7.

Sharer N et al. (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

external link
8.

Cohn JA et al. (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

external link
9.

Chang MC et al. (2007) Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis.

external link
10.

Cheadle JP et al. (1992) A new missense mutation (R1283M) in exon 20 of the cystic fibrosis transmembrane conductance regulator gene.

external link
11.

Férec C et al. (1992) Detection of over 98% cystic fibrosis mutations in a Celtic population.

external link
12.

Rosenfeld MA et al. (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

external link
13.

Cutting GR et al. (1992) Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.

external link
14.

Fanen P et al. (1992) Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.

external link
15.

Snouwaert JN et al. (1992) An animal model for cystic fibrosis made by gene targeting.

external link
16.

Dorin JR et al. (1992) Cystic fibrosis in the mouse by targeted insertional mutagenesis.

external link
17.

Abeliovich D et al. (1992) Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

external link
18.

Cheadle J et al. (1992) Mild pulmonary disease in a cystic fibrosis child homozygous for R553X.

external link
19.

Laroche D et al. (1991) Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia.

external link
20.

Rich DP et al. (1990) Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.

external link
21.

Devoto M et al. (1991) Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy.

external link
22.

Marino CR et al. (1991) Localization of the cystic fibrosis transmembrane conductance regulator in pancreas.

external link
23.

Dörk T et al. (1991) Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.

external link
24.

Nunes V et al. (1991) Analysis of 14 cystic fibrosis mutations in five south European populations.

external link
25.

Dumur V et al. (1990) Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion.

external link
26.

Curtis A et al. (1991) Association of less common cystic fibrosis mutations with a mild phenotype.

external link
27.

None (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

external link
28.

Klinger K et al. (1990) Cystic fibrosis mutations in the Hutterite Brethren.

external link
29.

Kerem BS et al. (1989) DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis.

external link
30.

Kerem B et al. (1989) Identification of the cystic fibrosis gene: genetic analysis.

external link
31.

Baylin SB et al. (1980) Age-related abnormalities of circulating polyamines and diamine oxidase activity in cystic fibrosis heterozygotes and homozygotes.

external link
32.

Colledge WH et al. (1995) Generation and characterization of a delta F508 cystic fibrosis mouse model.

external link
33.

Kerem E et al. (1995) Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.

external link
34.

Sheppard DN et al. (1993) Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.

external link
35.

Yang Y et al. (1993) An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.

external link
36.

Yang Y et al. (1993) Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR.

external link
37.

None (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium.

external link
38.

Johannesson M et al. (1997) Delayed puberty in girls with cystic fibrosis despite good clinical status.

external link
39.

de Vries HG et al. (1997) Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring.

external link
40.

None (1997) The diagnosis of cystic fibrosis.

external link
41.

Pier GB et al. (1998) Salmonella typhi uses CFTR to enter intestinal epithelial cells.

external link
42.

Dörk T et al. (1998) Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G-->A in diverse populations.

external link
43.

Reddy MM et al. (1999) Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function.

external link
44.

Wang J et al. (2000) A novel mutation in the CFTR gene correlates with severe clinical phenotype in seven Hispanic patients.

external link
45.

Kabra M et al. (2000) Is the spectrum of mutations in Indian patients with cystic fibrosis different?

external link
46.

Kulczycki LL et al. (2003) A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations.

external link
47.

Egan ME et al. (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

external link
48.

van de Vosse E et al. (2005) Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR).

external link
49.

Romey MC et al. (1999) First putative sequence alterations in the minimal CFTR promoter region.

external link
50.

Kälin N et al. (1999) DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.

external link
51.

Chanson M et al. (1999) Defective regulation of gap junctional coupling in cystic fibrosis pancreatic duct cells.

external link
52.

Haardt M et al. (1999) C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation.

external link
53.

Chang XB et al. (1999) Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis.

external link
54.

Romey MC et al. () Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone.

external link
55.

Romey MC et al. (2000) A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression.

external link
56.

Weixel KM et al. (2000) The carboxyl terminus of the cystic fibrosis transmembrane conductance regulator binds to AP-2 clathrin adaptors.

external link
57.

Ellsworth RE et al. (2000) Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

external link
58.

Mickle JE et al. (2000) Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.

external link
59.

Dörk T et al. (2000) Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe.

external link
60.

Gomez Lira M et al. (2000) High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia.

external link
61.

Moyer BD et al. (2000) The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane.

external link
62.

Wang S et al. (2000) Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity.

external link
63.

Callen A et al. (2000) A simplified cyclic adenosine monophosphate-mediated sweat rate test for quantitative measure of cystic fibrosis transmembrane regulator (CFTR) function.

external link
64.

Scotet V et al. (2001) Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis.

external link
65.

Choi JY et al. (2001) Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.

external link
66.

Buratti E et al. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

external link
67.

Rowntree RK et al. (2001) An element in intron 1 of the CFTR gene augments intestinal expression in vivo.

external link
68.

Bronsveld I et al. (2001) Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.

external link
69.

White SM et al. (2001) Cystic fibrosis: a further case of an asymptomatic compound heterozygote.

external link
70.

Broackes-Carter FC et al. (2002) Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy.

external link
71.

Dickinson P et al. (2002) The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics.

external link
72.

Oceandy D et al. (2002) Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities.

external link
73.

Bobadilla JL et al. (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.

external link
74.

Hefferon TW et al. (2002) Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping.

external link
75.

Eidelman O et al. (2002) Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR.

external link
76.

Mouchel N et al. (2003) Alternative 5' exons of the CFTR gene show developmental regulation.

external link
77.

Pagani F et al. (2003) New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12.

external link
78.

Sheth S et al. (2003) Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

external link
79.

Reddy MM et al. (2003) Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells.

external link
80.

Trezise AE et al. (1992) Localization of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) in the rat to chromosome 4 and implications for the evolution of mammalian chromosomes.

external link
81.

Yang H et al. (2003) Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.

external link
82.

Alper OM et al. (2003) 1154insTC is not a rare CFTR mutation.

external link
83.

Wong LJ et al. (2003) Two novel null mutations in a Taiwanese cystic fibrosis patient and a survey of East Asian CFTR mutations.

external link
84.

Jones CT et al. (1992) Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation.

external link
85.

Nunes V et al. (1992) Cystic fibrosis patients with mutation 1949del84 in exon 13 of the CFTR gene have a similar clinical severity as delta F508 homozygotes.

external link
86.

Strong TV et al. (1992) Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

external link
87.

Aznarez I et al. (2003) Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.

external link
88.

Lee JH et al. (2003) A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases.

external link
89.

Waterston R et al. (1992) A survey of expressed genes in Caenorhabditis elegans.

external link
90.

McCombie WR et al. (1992) Caenorhabditis elegans expressed sequence tags identify gene families and potential disease gene homologues.

external link
91.

Zeitlin PL et al. (1992) CFTR protein expression in primary and cultured epithelia.

external link
92.

Shoshani T et al. (1992) Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

external link
93.

Casals T et al. (1992) Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin.

external link
94.

Ronchetto P et al. (1992) A nonsense mutation (R1158X) and a splicing mutation (3849 + 4A----G) in exon 19 of the cystic fibrosis transmembrane conductance regulator gene.

external link
95.

Fonknechten N et al. (1992) CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts.

external link
96.

Granell R et al. (1992) Identification of a nonframeshift 84-bp deletion in exon 13 of the cystic fibrosis gene.

external link
97.

Nunes V et al. (1992) A frameshift mutation (2869insG) in the second transmembrane domain of the CFTR gene: identification, regional distribution, and clinical presentation.

external link
98.

Graham CA et al. (1992) Identification of a frameshift mutation (557 del T) in exon 4 of the CFTR gene.

external link
99.

Dean M et al. (1992) A 22-bp deletion in the coding region of the cystic fibrosis gene.

external link
100.

Kelley KA et al. (1992) Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulator.

external link
101.

Lerer I et al. (1992) Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

external link
102.

Claustres M et al. (1992) A new mutation (1078delT) in exon 7 of the CFTR gene in a southern French adult with cystic fibrosis.

external link
103.

Hamosh A et al. (1992) Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.

external link
104.

Ferrie RM et al. (1992) Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.

external link
105.

Denning GM et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

external link
106.

Osborne L et al. (1992) Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene.

external link
107.

Gasparini P et al. (1992) Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease.

external link
108.

Grebe TA et al. (1992) Mutation analysis of the cystic fibrosis transmembrane regulator gene in Native American populations of the southwest.

external link
109.

Siegel D et al. (1992) Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.

external link
110.

Wang XF et al. (2003) Involvement of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm.

external link
111.

Wilschanski M et al. (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

external link
112.

Mendes F et al. (2003) Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein.

external link
113.

Wang HY et al. (2004) Structural diversity and functional implications of the eukaryotic TDP gene family.

external link
114.

Groman JD et al. (2004) Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

external link
115.

Randak C et al. (2003) An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR.

external link
116.

Hefferon TW et al. (2004) A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing.

external link
117.

Fischer H et al. (2004) Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel.

external link
118.

Audrézet MP et al. (2004) Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms.

external link
119.

Buratti E et al. (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.

external link
120.

Rozen R et al. (1992) Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis.

external link
121.

Anguiano A et al. (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis.

external link
122.

Salvatore D et al. (2005) Isolated elevated sweat chloride concentrations in the presence of the rare mutation S1455X: an extremely mild form of CFTR dysfunction.

external link
123.

Vergani P et al. (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.

external link
124.

Clain J et al. (2005) A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

external link
125.

Clain J et al. (2005) Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.

external link
126.

Pagani F et al. (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution.

external link
127.

Derichs N et al. (2005) Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.

external link
128.

Chen HJ et al. (2005) Cystic fibrosis with homozygous R553X mutation in a Taiwanese child.

external link
129.

Wauters JG et al. (1991) Frequency of the phenylalanine deletion (delta F508) in the CF gene of Belgian cystic fibrosis patients.

external link
130.

Jin R et al. (2006) The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice.

external link
131.

Sun W et al. (2006) CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype.

external link
132.

Bürger J et al. (1991) Genetic influences in the formation of nasal polyps.

external link
133.

Bal J et al. (1991) A cystic fibrosis patient homozygous for the nonsense mutation R553X.

external link
134.

Younger JM et al. (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.

external link
135.

Di A et al. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity.

external link
136.

Cutting GR et al. (1990) A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.

external link
137.

Cheng SH et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

external link
138.

Anand R et al. (1991) A yeast artificial chromosome contig encompassing the cystic fibrosis locus.

external link
139.

Chu CS et al. (1991) Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

external link
140.

Zielenski J et al. (1991) Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

external link
141.

Ivaschenko TE et al. (1991) A deletion of two nucleotides in exon 10 of the CFTR gene in a Soviet family with cystic fibrosis causing early infant death.

external link
142.

Wang X et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

external link
143.

Tata F et al. (1991) Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene.

external link
144.

Gregory RJ et al. (1991) Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.

external link
145.

Trapnell BC et al. (1991) Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis.

external link
146.

Morral N et al. (1991) CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossingover.

external link
147.

Zielenski J et al. (1991) A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

external link
148.

Hamosh A et al. (1991) Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

external link
149.

White MB et al. (1991) A de novo cystic fibrosis mutation: CGA (Arg) to TGA (stop) at codon 851 of the CFTR gene.

external link
150.

Thelin WR et al. (2007) Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR.

external link
151.

Aznarez I et al. (2007) Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.

external link
152.

Daigneault J et al. (1991) Genetic epidemiology of cystic fibrosis in Saguenay-Lac-St-Jean (Quebec, Canada).

external link
153.

Chalkley G et al. (1991) A cystic fibrosis patient who is homozygous for the G85E mutation has very mild disease.

external link
154.

Chalkley G et al. (1991) Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene.

external link
155.

Serohijos AW et al. (2008) Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

external link
156.

Sangiuolo F et al. (1991) A serine-to-arginine (AGT-to-CGT) mutation in codon 549 of the CFTR gene in an Italian patient with severe cystic fibrosis.

external link
157.

Strong TV et al. (1991) Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels.

external link
158.

Kobayashi K et al. (1990) Benign missense variations in the cystic fibrosis gene.

external link
159.

Thauvin-Robinet C et al. (2009) The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.

external link
160.

Chehab FF et al. (1991) A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the delta F508 mutation: implications for prenatal diagnosis and mutation origin.

external link
161.

Iannuzzi MC et al. (1991) Two frameshift mutations in the cystic fibrosis gene.

external link
162.

Gille C et al. (1991) A pooling strategy for heterozygote screening of the delta F508 cystic fibrosis mutation.

external link
163.

Osborne L et al. (1991) A mutation in the second nucleotide binding fold of the cystic fibrosis gene.

external link
164.

Nelson PV et al. (1991) Identification of a cystic fibrosis mutation: deletion of isoleucine506.

external link
165.

Gasparini P et al. (1991) The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences.

external link
166.

Okiyoneda T et al. (2010) Peripheral protein quality control removes unfolded CFTR from the plasma membrane.

external link
167.

Hutt D et al. (2010) Cell Biology. The proteome in balance.

external link
168.

Cuppens H et al. (1990) A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew.

external link
169.

Vidaud M et al. (1990) Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

external link
170.

Guillermit H et al. (1990) A 3' splice site consensus sequence mutation in the cystic fibrosis gene.

external link
171.

Green ED et al. (1990) Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping.

external link
172.

Rozen R et al. (1990) Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families.

external link
173.

Kerem E et al. (1990) The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

external link
174.

Cutting GR et al. (1990) Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease.

external link
175.

Kerem BS et al. (1990) Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

external link
176.

Ballabio A et al. (1990) PCR test for cystic fibrosis deletion.

external link
177.

Dean M et al. (1990) Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients.

external link
178.

Latham T et al. (1990) Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

external link
179.

Riordan JR et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

external link
180.

Chan AM et al. (1989) Molecular cloning and localization to chromosome 6 of mouse INT1L1 gene.

external link
181.

Orita M et al. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

external link
182.

Rommens JM et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping.

external link
183.

Vidaud M et al. (1989) A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.

external link
184.

Burke JF et al. (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin.

external link
185.

Buchanan JH et al. (1987) Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy.

external link
186.

Konstan MW et al. (1995) Effect of high-dose ibuprofen in patients with cystic fibrosis.

external link
187.

Gasparini P et al. (1993) Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: their incidence and clinical features of defined genotypes.

external link
188.

Sangiuolo F et al. (1993) Molecular characterization of a frameshift mutation in exon 19 of the CFTR gene.

external link
189.

Kiesewetter S et al. (1993) A mutation in CFTR produces different phenotypes depending on chromosomal background.

external link
190.

Schwartz M et al. (1994) 394delTT: a Nordic cystic fibrosis mutation.

external link
191.

Grebe TA et al. (1994) Genetic analysis of Hispanic individuals with cystic fibrosis.

external link
192.

Shoshani T et al. (1994) Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.

external link
193.

Will K et al. (1994) A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.

external link
194.

Verlingue C et al. (1994) Retrospective study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Guthrie cards from a large cohort of neonatal screening for cystic fibrosis.

external link
195.

Pind S et al. (1994) Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

external link
196.

Logan J et al. (1994) Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.

external link
197.

Greil I et al. () A new missense mutation G1249E in exon 20 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

external link
198.

Shoshani T et al. (1994) Two novel mutations in the CFTR gene: W1089X in exon 17B and 4010delTATT in exon 21.

external link
199.

Ghanem N et al. (1994) Identification of eight mutations and three sequence variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

external link
200.

Schaedel C et al. (1994) A novel cystic fibrosis mutation, Y109C, in the first transmembrane domain of CFTR.

external link
201.

Romey MC et al. (1994) Two novel rare frameshift mutations (2423 del G in exon 13 and 1215 del G in exon 7) and one novel rare sequence variation (3271 + 18 C or T) identified in a patient with cystic fibrosis.

external link
202.

Russo MP et al. (1995) Analysis of linkage disequilibrium between different cystic fibrosis mutations and three intragenic microsatellites in the Italian population.

external link
203.

Schwiebert EM et al. (1995) CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP.

external link
204.

Leoni GB et al. (1995) A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration.

external link
205.

Rozen R et al. (1995) L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis.

external link
206.

Jensen TJ et al. (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.

external link
207.

van Doorninck JH et al. (1995) A mouse model for the cystic fibrosis delta F508 mutation.

external link
208.

Zeiher BG et al. (1995) A mouse model for the delta F508 allele of cystic fibrosis.

external link
209.

Zielenski J et al. (1995) CFTR gene variant for patients with congenital absence of vas deferens.

external link
210.

Varon R et al. (1995) Recurrent nasal polyps as a monosymptomatic form of cystic fibrosis associated with a novel in-frame deletion (591del18) in the CFTR gene.

external link
211.

Shoshani T et al. (1993) A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews.

external link
212.

Guillermit H et al. (1993) A novel mutation in exon 3 of the CFTR gene.

external link
213.

Audrézet MP et al. (1993) Identification of 12 novel mutations in the CFTR gene.

external link
214.

Nunes V et al. (1993) A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype.

external link
215.

Chu CS et al. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.

external link
216.

Smit LS et al. (1993) An African-American cystic fibrosis patient homozygous for a novel frameshift mutation associated with reduced CFTR mRNA levels.

external link
217.

Welsh MJ et al. (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

external link
218.

Claustres M et al. (1993) Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France.

external link
219.

Bienvenu T et al. (1993) Male infertility as the only presenting sign of cystic fibrosis when homozygous for the mild mutation R117H.

external link
220.

Yang Y et al. (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

external link
221.

Mashal RD et al. (1995) Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases.

external link
222.

Chillón M et al. (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

external link
223.

Smit LS et al. (1995) Missense mutation (G480C) in the CFTR gene associated with protein mislocalization but normal chloride channel activity.

external link
224.

Youil R et al. (1995) Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII.

external link
225.

Lee YM et al. (1995) Primary sclerosing cholangitis.

external link
226.

Chillón M et al. (1994) A cystic fibrosis patient homozygous for the new frameshift mutation 936delTA: description and clinical data.

external link
227.

Orozco L et al. (1994) Identification of the I507 deletion by site-directed mutagenesis.

external link
228.

Dorval I et al. (1993) Analysis of 160 CF chromosomes: detection of a novel mutation in exon 20.

external link
229.

Augarten A et al. (1993) Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.

external link
230.

Romey MC et al. (1993) Rapid detection of single nucleotide deletions: application to the beta 6 (-A) mutation of the beta-globin gene and to cystic fibrosis.

external link
231.

Varon R et al. (1995) Pancreatic insufficiency and pulmonary disease in German and Slavic cystic fibrosis patients with the R347P mutation.

external link
232.

Costes B et al. (1995) Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens.

external link
233.

Dumur V et al. (1996) Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype.

external link
234.

Sato S et al. (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.

external link
235.

Howard M et al. (1996) Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.

external link
236.

Delaney SJ et al. (1996) Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations.

external link
237.

Pignatti PF et al. (1996) CFTR gene variant IVS8-5T in disseminated bronchiectasis.

external link
238.

French PJ et al. (1996) A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

external link
239.

Teng H et al. (1997) Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells.

external link
240.

Antiñolo G et al. (1997) Genotype-phenotype relationship in 12 patients carrying cystic fibrosis mutation R334W.

external link
241.

Castaldo G et al. (1997) Severe liver impairment in a cystic fibrosis-affected child homozygous for the G542X mutation.

external link
242.

Loirat F et al. (1997) G542X as a probable Phoenician cystic fibrosis mutation.

external link
243.

Brown CR et al. (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.

external link
244.

Randak C et al. (1997) A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase.

external link
245.

Girodon E et al. () CFTR gene mutations in adults with disseminated bronchiectasis.

external link
246.

Bedwell DM et al. (1997) Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.

external link
247.

Cuppens H et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

external link
248.

Casals T et al. (1997) High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes.

external link
249.

Kocher O et al. (1998) Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.

external link
250.

Mickle JE et al. (1998) A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.

external link
251.

Zhang F et al. (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.

external link
252.

Sato S et al. (1998) Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro.

external link
253.

de Meeus A et al. (1998) Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.

external link
254.

Devor DC et al. (1998) Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion.

external link
255.

Jiang Q et al. (1998) Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.

external link
256.

Wei L et al. (1998) Phosphorylation site independent single R-domain mutations affect CFTR channel activity.

external link
257.

Ramjeesingh M et al. (1999) Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).

external link
258.

OMIM.ORG article

Omim 602421 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz